Xcout Intel
3DBiopsy, Inc.
3DBiopsy, Inc. operates as a medical device company that develops 3D mapping software, biopsy needles, biopsy actuators, and integrated pathology systems.
Subscribe to see 3DBiopsy, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
3DBiopsy, Inc. at a glance
3DBiopsy, Inc. is a medical devices company headquartered in United States. It has raised at least $2.3M across the 3 funding rounds on record. Its most recent funding round raised $850,000 in August 2018. Xcout tracks 11 named people at 3DBiopsy, Inc., including Brad J. Buscher (CEO & Executive Chairman of the Board).
3DBiopsy, Inc. leadership
- Brad J. BuscherCEO & Executive Chairman of the Board
- Gary HeathPresident & Director of Engineering
- Randy WhitakerChief Financial Officer
- Paul AranguaDirector of Research & Product Development
- John MannRegulatory Affairs & Quality Assurance Consultant
- Josh CohenSales & Marketing Consultant
5 more named people on record for 3DBiopsy, Inc., with roles, board committees and tenure — see the full roster →
3DBiopsy, Inc. funding rounds
At least $2.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $850,000 | 13 named | |
| SEC Form D filing | $83,500 | — | |
| SEC Form D filing | $1.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
3DBiopsy, Inc. competitors
A few of 3DBiopsy, Inc.'s closest competitors — see the full list of competitors and alternatives →
BiBB Instruments AB is a medical technology company that develops and manufactures EndoDrill®, a patented series of motorized endoscopic biopsy instruments designed to improve cancer diagnostics. The system uses an electric rotating needle technology to obtain high-quality core tissue samples during ultrasound-guided endoscopic procedures for various cancers, including gastrointestinal, lung, and urological malignancies.
URO-1, Inc. is a privately held medical device company established in 2017 and based in Greensboro, North Carolina. The company develops and manufactures surgical solutions and instruments for biopsy procedures, specifically focusing on prostate and soft tissue cancer diagnostics.
MedicaMetrix develops medical devices for prostate health, specifically offering the ProstaMetrix platform to measure prostate volume and calculate Prostate Specific Antigen Density (PSAD) during routine clinical examinations. The company serves urologists and healthcare professionals by providing tools for the early detection and ongoing monitoring of prostate conditions such as prostate cancer and BPH.
Resolution Biomedical develops and manufactures liquid-based cytology systems and specimen collection supplies, including the Gynemed Brush and COVID-19 transport tubes.
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Get 3DBiopsy, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on 3DBiopsy, Inc. in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access